{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-043555","form_type":"8-K/A","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2023-08-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.694298+00:00","generated_at":"2026-06-11T06:03:38.979451+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Precision BioSells CAR T manufacturing to Imugene for $8M cash and $13M convertible notes","bullets":["Imugene acquired CAR T manufacturing infrastructure, including MCAT facility, for $8M cash and $13M in 1-year non-interest-bearing convertible notes.","Pro forma net loss for H1 2023 reduced from $37M to $22M, reflecting discontinued CAR T operations.","Precision granted Imugene exclusive license to develop/commercialize azer-cel and up to three additional CAR T candidates.","Pro forma balance sheet shows $146M cash; convertible note receivable of $12M at estimated fair value.","Transaction results in estimated $10M gain recorded in discontinued operations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-043555","json":"https://secwatch.observer/filing/0000950170-23-043555.json","markdown":"https://secwatch.observer/filing/0000950170-23-043555.md","text":"https://secwatch.observer/filing/0000950170-23-043555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023043555/0000950170-23-043555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023043555/dtil-20230815.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T06:03:38.979451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}